McHenry T. Tichenor, Managing Member at Tichenor Ventures, Dallas, TX — verified investor profile. See sector focus and contact routes.
McHenry “Mac” Tichenor is the President and Director & Managing Partner of Tichenor Ventures, a Dallas-based private investment company formed in 2010 (with some sources citing 2019) that concentrates on early-stage life sciences and biotechnology investments[1][2][3]. His investment thesis targets early-stage biotech companies, primarily in the life sciences, biotechnology, and healthcare sectors, with a geographic focus on the United States, particularly Dallas[1][3][9]. While specific check sizes and lead/follow behavior are not publicly documented, the firm’s latest known investment was a Series A round in OS Therapies in April 2021, suggesting participation in early growth stages[8]. Notable portfolio companies include Dose Therapeutics, where Tichenor serves as a Director, and OS Therapies, which received the firm’s most recent investment[3][8]. Tichenor’s distinctive point of view stems from personal experience: after losing his son Willie to cancer, he focuses on developing less toxic cancer treatments and supports sarcoma research through the QuadW Foundation and the Osteosarcoma Institute, where he holds leadership roles[3][6]. He holds an M.S. in biotechnology from The U
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Dallas.
Investors like McHenry T. Tichenor · Full investor directory · Investor access · Company funding database